Advanced treatment at Loyola University Medical Center is offering remission from a rare blood cancer. Thanks to Loyola’s ...

A Cavan woman battling a rare and incurable form of bone marrow cancer hopes to run her 600th lifetime marathon by June of ...

Pomalyst (pomalidomide) is a prescription drug that’s used to treat multiple myeloma in adults. Pomalyst is also available as a generic drug. Pomalyst comes as an oral capsule. The active ...

Firefighters, police officer who responded to 9/11 in World Trade Center do have an increased risk of multiple myeloma. There are some other well-defined occupational exposures. For instance ...

In this video interview, Michael Andreini, president and CEO of the Multiple Myeloma Research Foundation, highlights how the MMRF accelerates trial timelines for biopharmas by integrating an adaptive ...

Background: Multiple myeloma (MM), a malignant disease of plasma cells originating in the bone marrow, is influenced significantly by genetic factors. Although plasma liposomes have been linked to MM, ...

Velcade is used in adults to treat multiple myeloma and mantle cell lymphoma. Keep reading to learn about the common, mild, and serious side effects Velcade can cause. To learn more about Velcade ...

which recently have shown to have antitumor activity in multiple myeloma, may also be of therapeutic value in treating primary amyloidosis (Gertz, 2002; Khan & Falk, 2001). A more aggressive ...

Department of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum der Charité, Berlin, Germany (M.L.M., U.L., B.H., D.M., A.B., I.M., S.S ...

Multiple myeloma (also referred to as myeloma) is a type of rare, incurable cancer of the blood—also known as hematologic cancer. It affects cells called plasma cells, which are types of white blood ...

Medically reviewed by Marla Anderson, MD Multiple myeloma is a rare blood cancer that develops in the plasma cells, which are white blood cells that help you fight infection by making antibodies.